Opinions
Alex Ruus
Neptune Tech & Bioresource
NEPT-T
PAST TOP PICK
Feb 02, 2016
$1.570
Stock price when the opinion was issued
biotechnology
pharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.
You might be interested:
SHORT
For years NEPT was in partnerships where they were extracting Omega-3 oils from krill oil and selling that to consumers. Now they're taking that extraction technology and applying it to the cannabis oil market. He's in a wait-and-see spots. The fundamentals don't back the move up in the stock. He has a small short on this.
(A Top Pick Dec 10/14. Down 26.57%.) Healthcare company. Has a lot of upside because they are developing a drug for treatment of hypertriglyceridemia. It should hopefully go into phase 3 trials by next year. Technically it is starting to outperform now. New CEO. A table pounder at this price.